The HCC‐domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction

Molecular Microbiology - Tập 51 Số 3 - Trang 631-643 - 2004
Andreas Rummel1, Stefan Mahrhold1, Hans Bigalke2, Thomas Binz1
1Institute of Biochemistry, Medizinische Hochschule Hannover, D‐30623 Hannover, Germany.
2Institute of Toxicology, Medizinische Hochschule Hannover, D-30623 Hannover, Germany.

Tóm tắt

Summary

Tetanus and botulinum neurotoxins selectively invade neurons following binding to complex gangliosides. Recent biochemical experiments demonstrate that two ganglioside binding sites within the tetanus neurotoxin HC‐fragment, originally identified in crystallographic studies to bind lactose or sialic acid, are required for productive binding to target cells. Here, we determine by mass spectroscopy studies that the HC‐fragment of botulinum neurotoxins A and B bind only one molecule of ganglioside GT1b. Mutations made in the presumed ganglioside binding site of botulinum neurotoxin A and B abolished the formation  of  these  HC‐fragment/ganglioside  complexes, and drastically diminished binding to neuronal membranes and isolated GT1b. Furthermore, correspondingly mutated full‐length neurotoxins exhibit significantly reduced neurotoxicity, thus identifying a single ganglioside binding site within the carboxyl‐terminal half of the HC‐fragment of botulinum neurotoxins A and B. These binding cavities are defined by the conserved peptide motif H…SXWY…G. The roles of tyrosine and histidine in botulinum neurotoxins A and B in ganglioside binding differ from those in the analogous tetanus neurotoxin lactose site. Hence, these findings provide valuable information for the rational design of potent botulinum neurotoxin binding inhibitors.

Từ khóa


Tài liệu tham khảo

Bakry N., 1991, Tetanus toxin and neuronal membranes: the relationship between binding and toxicity, J Pharmacol Exp Ther, 0, 613

10.1007/978-3-662-05971-5_18

Binz T., 1990, The complete sequence of botulinum neurotoxin type A and comparison with other clostridial neurotoxins, J Biol Chem, 265, 9153, 10.1016/S0021-9258(19)38824-6

10.1021/bi0157969

10.1083/jcb.200305098

10.1074/jbc.275.12.8889

10.1074/jbc.M103285200

10.1007/BF00500299

10.1016/S0021-9258(18)82109-3

10.1007/978-3-642-85173-5_10

10.1046/j.1471-4159.2000.0741941.x

10.1042/0264-6021:3470199

10.1091/mbc.12.10.2947

10.1038/249415a0

10.1099/00221287-24-1-107

10.1016/0304-4165(80)90382-7

Knapp M., 1998, The 1.61 Ångström structure of the tetanus toxin ganglioside binding region: solved by MAD and mir phase combination, Am Cryst Assoc Abstract Papers, 25, 90

10.1038/nsb879

10.1006/mpat.1998.0214

10.1038/2338

10.1242/jcs.112.16.2715

10.1021/bi00370a044

10.1016/0968-0004(86)90282-3

10.1006/bbrc.2001.6031

Niemann H., 1991, Sourcebook of Bacterial Protein Toxins., 303

10.1016/0962-8924(94)90203-8

Nishiki T., 1994, Identification of the protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes, J Biol Chem, 269, 10498, 10.1016/S0021-9258(17)34087-5

10.1016/0014-5793(95)01471-3

10.1016/0304-3940(96)12557-X

10.1016/0165-2478(89)90136-3

10.1042/bj2360845

Rummel A., 2001, Binding and axonal transport of recombinant tetanus toxins and fragments in nerve cell culture, Naunyn Schmiedeberg's Arch Pharmacol Supplement, 363, R21

10.1016/S0022-2836(02)01403-1

10.1111/j.1471-4159.1991.tb08253.x

10.1152/physrev.2000.80.2.717

10.1111/j.1471-4159.1971.tb03750.x

10.1038/78005

10.1038/nsb1097-788

10.1074/jbc.274.35.25173

10.1074/jbc.M205258200